Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Feb 23, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The goal of the proposed research is to refine, adapt and perform efficacy testing of a novel reinforcement learning-based text messaging intervention to support medication adherence for patients with type 2 diabetes within a community setting. Type 2 diabetes is an optimal condition in which to refine this program, as it is one of the most prevalent chronic conditions in the US adult population and requires most patients to be on daily or twice daily doses of medications. This study will be a parallel randomized pragmatic trial comparing medication adherence and clinical outcomes for adult...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Type 2 Diabetes Mellitus (T2DM)
- • Prescribed between 1-3 daily oral medications for diabetes
- • Most recent HbA1c level of 7% or greater
- • Suboptimal adherence, defined by proportion of days covered (PDC) \< 0.90 based on chart review
- • Must have a smartphone for which they are the sole user
- • Must have a basic working knowledge of English or Spanish
- Exclusion Criteria:
- • Currently using a pillbox and/or not willing to use electronic pill bottles for 6 months
- • Receive help at home on a daily basis with taking medications
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials